1
|
Yang WC, Zhu L, Qiu YM, Zhou BX, Cheng JL, Wei CL, Chen HC, Li LY, Fu XD, Fu JJ. Isolation and analysis of cell-free fetal DNA from maternal peripheral blood in Chinese women. Genet Mol Res 2015; 14:18078-89. [PMID: 26782455 DOI: 10.4238/2015.december.22.34] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Non-invasive prenatal diagnosis is used to detect the genetic material of the fetus by isolating the cell-free fetal DNA (cffDNA) from maternal peripheral blood. In order to establish an isolation method for cffDNA from maternal peripheral blood in Chinese women, the cffDNA was acquired with a two-step centrifugation using a QlAamp DNA Blood mini kit. The SRY gene of plasma DNA was amplified by polymerase chain reaction (PCR). Real-time quantitative PCR was used to measure the concentration of cffDNA in maternal peripheral blood in different pregnant women. The results of the SRY gene amplification of plasma DNA from pregnant women was the same as that of the amniocyte DNA. The average concentration of cffDNA in maternal peripheral blood of pregnant women in different gestational stages was 0.98 ng/mL (0.26-1.49 ng/mL), 1.43 ng/mL (0.46- 2.34 ng/mL), and 1.95 ng/mL (0.65-6.81 ng/mL) from early, middle, and late gestational stages, respectively. The mean of cffDNA from total DNA in plasma in different stages of gestation was 22.28% (9.86-27.81%). The lowest concentration of DNA amplified by nested-PCR in our research was 10-4-10-3 ng/μL. The isolation method for cffDNA from maternal peripheral blood was successfully established and further research into its applications will be conducted.
Collapse
Affiliation(s)
- W C Yang
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Sichuan Medical University, Luzhou City, Sichuan Province, China
| | - L Zhu
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Sichuan Medical University, Luzhou City, Sichuan Province, China
| | - Y M Qiu
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Sichuan Medical University, Luzhou City, Sichuan Province, China.,Maternal and Child Health Care Hospital of Zigong, Zigong, Sichuan Province, China
| | - B X Zhou
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Sichuan Medical University, Luzhou City, Sichuan Province, China
| | - J L Cheng
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Sichuan Medical University, Luzhou City, Sichuan Province, China
| | - C L Wei
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Sichuan Medical University, Luzhou City, Sichuan Province, China.,State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau (SAR), China
| | - H C Chen
- Department of Biochemistry, School of Life Sciences & the State Key Laboratory of Medical Genetics, Central South University, Changsha, Hunan Province, China
| | - L Y Li
- Institute of Reproduction and Stem Cell Engineering, Central South University Xiangya School of Medicine, Changsha, Hunan Province, China
| | - X D Fu
- Department of Obstetrics and Gynecology, First Affiliated Hospital of Sichuan Medical University, Luzhou, Sichuan Province, China
| | - J J Fu
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Sichuan Medical University, Luzhou City, Sichuan Province, China.,State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau (SAR), China.,Department of Obstetrics and Gynecology, First Affiliated Hospital of Sichuan Medical University, Luzhou, Sichuan Province, China
| |
Collapse
|
2
|
Chen BL, Wang W, Xie H, Ge RR, Zhang ZY, Li ZW, Zhou XY, Zhou BX. Phase transformation of Cu-rich precipitates from 9R to 3R variant via ledges mechanism in ferritic steel containing copper. J Microsc 2015; 262:123-7. [PMID: 26599818 DOI: 10.1111/jmi.12352] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2015] [Accepted: 10/28/2015] [Indexed: 11/29/2022]
Abstract
Precipitates and solute enrich in aged ferritic steel containing copper were examined using high-resolution electron microscopy, high-angle annular dark-field scanning transmission electron microscopy and energy-dispersive X-ray spectroscopy. Two ledges with one-atom and two-atom layers height in the 9R/3R interface were observed. The enrichment of copper into two successive closed-packed planes with an interval of Fe-rich close-packed plane was detected. The passage of the Shockley partial, or the shearing, changes the stacking sequence of closed-packed planes. Finally, 9R Cu variant transformed into 3R Cu variant.
Collapse
Affiliation(s)
- B L Chen
- School of Materials Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
| | - W Wang
- School of Materials Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
| | - H Xie
- School of Materials Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
| | - R R Ge
- School of Materials Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
| | - Z Y Zhang
- School of Materials Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
| | - Z W Li
- School of Materials Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
| | - X Y Zhou
- School of Materials Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
| | - B X Zhou
- Institute of Materials, Shanghai University, Shanghai, People's Republic of China
| |
Collapse
|
3
|
Yang WC, Zhu L, Zhou BX, Tania S, Zhou Q, Khan MA, Fu XL, Cheng JL, Lv HB, Fu JJ. Establishment and rapid detection of a heterozygous missense mutation in the CACNA1F gene by ARMS technique with double-base mismatched primers. Genet Mol Res 2015; 14:11480-7. [PMID: 26436388 DOI: 10.4238/2015.september.25.14] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Retinitis pigmentosa (RP) is a retinal degenerative disorder that often causes complete blindness. Mutations of more than 50 genes have been identified as associated with RP, including the CACNA1F gene. In a recent study, by employing next-generation sequencing, we identified a novel mutation in the CACNA1F gene. In this study, we used the amplification refractory mutation system (ARMS) and identified a single nucleotide change c.1555C>T in exon 13 of the CACNA1F gene, leading to the substitution of arginine by tryptophan (p.R519W) in a Chinese individual affected by RP. This study actually confirms this novel mutation, and establishes the ARMS technique for the detection of mutations in RP.
Collapse
Affiliation(s)
- W C Yang
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Luzhou Medical College, Luzhou, Sichuan, China
| | - L Zhu
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Luzhou Medical College, Luzhou, Sichuan, China
| | - B X Zhou
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Luzhou Medical College, Luzhou, Sichuan, China
| | - S Tania
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Luzhou Medical College, Luzhou, Sichuan, China
| | - Q Zhou
- Department of Ophthalmology, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan, China
| | - M A Khan
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Luzhou Medical College, Luzhou, Sichuan, China
| | - X L Fu
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Luzhou Medical College, Luzhou, Sichuan, China
| | - J L Cheng
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Luzhou Medical College, Luzhou, Sichuan, China
| | - H B Lv
- Department of Ophthalmology, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan, China
| | - J J Fu
- Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Luzhou Medical College, Luzhou, Sichuan, China
| |
Collapse
|
4
|
Parhira S, Yang ZF, Zhu GY, Chen QL, Zhou BX, Wang YT, Liu L, Bai LP, Jiang ZH. In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea. PLoS One 2014; 9:e104544. [PMID: 25102000 PMCID: PMC4125211 DOI: 10.1371/journal.pone.0104544] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2014] [Accepted: 07/10/2014] [Indexed: 12/03/2022] Open
Abstract
A new lignan glycoside, (+)-pinoresinol 4-O-[6″-O-vanilloyl]-β-d-glucopyranoside (1) and two known phenolic compounds, 6′-O-vanilloyltachioside (2) and 6′-O-vanilloylisotachioside (3) were isolated from the latex of Calotropis gigantea (Asclepiadaceae). The structure of the new compound was elucidated by using spectroscopic and chemical methods. Three isolates (1–3) and one authentic compound, (+)-pinoresinol 4-O-β-d-glucopyranoside, were screened for A/PR/8/34 (H1N1) inhibitory activity by cytopathic effect (CPE) inhibition assay on MDCK cells. Compound 1 showed inhibitory activity against A/PR/8/34 (H1N1). In sharp contrast, the other three compounds (2, 3 and (+)-pinoresinol 4-O-β-d-glucopyranoside) did not show such activity. An analysis of structure-activity relationship between 1 and (+)-pinoresinol 4-O-β-d-glucopyranoside revealed that the presence of a vanilloyl group in the sugar moiety of 1 is crucial for its anti-influenza virus activity. Compound 1 was further evaluated for in vitro inhibitory activities against a panel of human and avian influenza viruses by CPE inhibition assay. It showed inhibitory effect against human influenza viruses in both subtypes A and B (IC50 values around 13.4–39.8 µM with SI values of 3.7–11.4), while had no effect on avian influenza viruses. Its antiviral activity against human influenza viruses subtype A was further confirmed by plaque reduction assay. The time course assay indicated that 1 exerts its antiviral activity at the early stage of viral replication. A mechanistic study showed that 1 efficiently inhibited influenza virus-induced activation of NF-κB pathway in a dose-dependent manner, but had no effect on virus-induced activation of Raf/MEK/ERK pathway. Further studies demonstrated that nuclear translocation of transcription factor NF-κB induced by influenza virus was significantly blocked by 1, meanwhile, nuclear export of viral ribonucleoproteins was also effectively inhibited. These findings suggest that this new lignan glycoside from Calotropis gigantea, may have therapeutic potential in influenza virus infection through inhibition of NF-κB pathway and viral ribonucleoproteins nuclear export.
Collapse
Affiliation(s)
- Supawadee Parhira
- State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau
| | - Zi-Feng Yang
- State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China
| | - Guo-Yuan Zhu
- State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau
| | - Qiao-Lian Chen
- State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China
| | - Bei-Xian Zhou
- State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China
| | - Yu-Tao Wang
- State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China
| | - Liang Liu
- State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau
| | - Li-Ping Bai
- State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau
- * E-mail: (LPB); (ZHJ)
| | - Zhi-Hong Jiang
- State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau
- * E-mail: (LPB); (ZHJ)
| |
Collapse
|